China
· Delayed Price · Currency is CNY Beijing Wantai Biological Pharmacy Enterprise Statistics
Total Valuation
Beijing Wantai Biological Pharmacy Enterprise has a market cap or net worth of CNY 86.83 billion. The enterprise value is 81.66 billion.
| Market Cap | 86.83B |
| Enterprise Value | 81.66B |
Important Dates
The next estimated earnings date is Friday, October 18, 2024.
| Earnings Date | Oct 18, 2024 |
| Ex-Dividend Date | Jun 3, 2024 |
Share Statistics
Beijing Wantai Biological Pharmacy Enterprise has 1.27 billion shares outstanding. The number of shares has decreased by -1.94% in one year.
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | -1.94% |
| Shares Change (QoQ) | -2.66% |
| Owned by Insiders (%) | 24.10% |
| Owned by Institutions (%) | 3.31% |
| Float | 256.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 58.61 |
| PS Ratio | 31.43 |
| PB Ratio | 6.68 |
| P/FCF Ratio | 176.49 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -420.50 |
| EV / Sales | 30.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 165.98 |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 2.02.
| Current Ratio | 4.48 |
| Quick Ratio | 4.04 |
| Debt / Equity | 2.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.52 |
| Interest Coverage | -78.96 |
Financial Efficiency
Return on equity (ROE) is -1.53% and return on invested capital (ROIC) is -2.28%.
| Return on Equity (ROE) | -1.53% |
| Return on Assets (ROA) | -1.93% |
| Return on Capital (ROIC) | -2.28% |
| Revenue Per Employee | 731,317 |
| Profits Per Employee | -52,344 |
| Employee Count | 3,843 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.57% in the last 52 weeks. The beta is 2.25, so Beijing Wantai Biological Pharmacy Enterprise's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | +37.57% |
| 50-Day Moving Average | 68.52 |
| 200-Day Moving Average | 65.73 |
| Relative Strength Index (RSI) | 47.15 |
| Average Volume (20 Days) | 3,267,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Wantai Biological Pharmacy Enterprise had revenue of CNY 2.71 billion and -194.20 million in losses. Loss per share was -0.16.
| Revenue | 2.71B |
| Gross Profit | 1.77B |
| Operating Income | -486.30M |
| Pretax Income | -283.12M |
| Net Income | -194.20M |
| EBITDA | -252.99M |
| EBIT | -486.30M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 5.62 billion in cash and 257.46 million in debt, giving a net cash position of 5.36 billion or 4.23 per share.
| Cash & Cash Equivalents | 5.62B |
| Total Debt | 257.46M |
| Net Cash | 5.36B |
| Net Cash Per Share | 4.23 |
| Equity (Book Value) | 12.74B |
| Book Value Per Share | 10.26 |
| Working Capital | 7.15B |
Cash Flow
In the last 12 months, operating cash flow was 1.50 billion and capital expenditures -1.01 billion, giving a free cash flow of 492.00 million.
| Operating Cash Flow | 1.50B |
| Capital Expenditures | -1.01B |
| Free Cash Flow | 492.00M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 65.10%, with operating and profit margins of -17.92% and -7.16%.
| Gross Margin | 65.10% |
| Operating Margin | -17.92% |
| Pretax Margin | -10.43% |
| Profit Margin | -7.16% |
| EBITDA Margin | -9.32% |
| EBIT Margin | -17.92% |
| FCF Margin | 18.13% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 0.47%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 0.47% |
| Dividend Growth (YoY) | -68.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 1.94% |
| Shareholder Yield | 2.41% |
| Earnings Yield | -0.23% |
| FCF Yield | 0.57% |
Stock Splits
The last stock split was on June 5, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 5, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |